Form D — Paragon Biosciences Emalex Capital, Inc.
0001749990-25-000002 · filed Mar 25, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $242,000,000
- Reported amount sold
- $217,000,000
- Minimum investment
- $1,072
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Paragon Biosciences Emalex Capital, Inc.
- CIK
- 1749990
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 303 N WABASH AVE
CHICACO, IL 60611 - Phone
- (847) 715-0606
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick J. Morris · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Jeffrey Aronin · DirectorChicago, IL Find on LinkedIn ↗
-
Antonio Gracias · DirectorChicago, IL Find on LinkedIn ↗
-
Darien Parhad · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Eric Messner · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Darien Parhad · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Jeffrey Dayno · DirectorChicago, IL Find on LinkedIn ↗
-
Ricky Sun · DirectorChicago, IL Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗